Don also served as Director, Legal for Cytogen Corporation (NASDAQ: CYTO), a publicly - traded
biopharmaceutical company with an established product line in prostate cancer therapeutics and other areas of oncology.
NGM Bio is a research - driven, clinical stage
biopharmaceutical company with a drug discovery platform that has generated a pipeline of first - in - class biologic development candidates.
About CytomX Therapeutics CytomX Therapeutics is a clinical - stage
biopharmaceutical company with a deep and differentiated oncology pipeline of investigational Probody ™ therapeutics.
GigaGen is a fast - growing
biopharmaceutical company with a mission to make a difference in the way life - changing medicines are discovered and developed.
Not exact matches
Alder BioPharmaceuticals, Inc., is a clinical - stage
biopharmaceutical company committed to transforming the treatment paradigm for patients
with migraine and other serious neurological or inflammatory conditions.
Google - backed biotech
company Calico has also forged a partnership
with a Chicago - based
biopharmaceutical firm to develop age - defying drugs.
The best stock performer in the 500 - stock index, though, was
biopharmaceutical company Nektar
with a 78 percent gain over the past three months.
To this end, Calico has also forged a partnership
with a Chicago - based
biopharmaceutical company called AbbVie, in order to develop drugs that will tackle aging and age - related diseases such as neurodegeneration and cancer.
We discovered our lead compounds, cabozantinib and cobimetinib, and advanced them into clinical development before entering into partnerships
with leading
biopharmaceutical companies in our efforts to bring these medicines to patients globally.
Both Price and Gottlieb were questioned on their intimate involvement
with biopharmaceutical and health care
companies by lawmakers; Price specifically was the subject of sharp ethics questions about his financial investments in medical firms that would also benefit from legislation he was pushing while serving in the House of Representatives.
Retailer Williams - Sonoma,
biopharmaceutical company Medivation and bank Wells Fargo ranked as the
companies with the most high - ranking positions held by women, researchers said.
Transition Therapeutics is a
biopharmaceutical company, developing novel therapeutics for disease indications
with large markets.
Insmed Incorporated, a
biopharmaceutical company, focuses on the development and commercialization of therapies for patients
with rare diseases.
Biotech
with Deep Pipeline, «Abundant» Upcoming Catalysts Named Top Pick Source: Streetwise Reports (4/11/18) Douglas Loe, an analyst
with Echelon Wealth Partners, made the case for why this
biopharmaceutical company merits this status.
Douglas Loe, an analyst
with Echelon Wealth Partners, made the case for why this
biopharmaceutical company merits this status.
Analyst Grant Zeng of Zacks Small Cap Research examines what transpired
with this
biopharmaceutical company during Q3 / 17.
Maastricht, The Netherlands, 1 November 2017 — Cristal Therapeutics, a clinical stage
biopharmaceutical company developing targeted nanomedicines for the treatment of cancer and other diseases
with high unmet patient need, announced today that it has begun a Phase 1b...
The clinical - stage
biopharmaceutical company committed to developing novel medicines to transform the lives of patients
with life - altering central nervous system (CNS) disorders, SAGE Therapeutics Inc. (NASDAQ: SAGE) seem to be poised for a price surge as per its latest charts.
Governor Andrew Cuomo's office announced last week, that a large
biopharmaceutical company will be investing millions of dollars
with the aim of creating a manufacturing and development center at Pfizer's large campus in Pearl River.
This position allows me to coordinate activities
with university groups and large biotech and
biopharmaceutical companies.
Part of the reason for that tight market is that industrial careers in plant biology are more limited in scope than those in, say,
biopharmaceuticals, where the industry is filled
with many
companies and opportunities.
An online survey conducted by the Clinical Data Interchange Standards Consortium (CDISC) and CenterWatch1
with 750 respondents — including investigative site personnel (355),
biopharmaceutical companies (211), service providers for the industry (146), and technology providers (38)-- yielded the following results:
AbbVie is a new global, research - based
biopharmaceutical company that combines the focus and passion of a leading - edge biotech,
with the expertise and results of a long - established pharmaceutical leader.
In Texas the Ebola patient is now stable but in critical condition and being treated
with brincidofovir, an oral medicine developed by Durham, N.C. — based
biopharmaceutical company, Chimerix.
On 29 September, AAAS hosted a lively online discussion on Reddit's «Ask Me Anything» (AMA) forum on implicit bias in science — a discussion Smith joined, along
with Shirley Malcom, AAAS» director of Education and Human Resources programs, Caleph B. Wilson, a biomedical scientist
with Cellectis, a
biopharmaceutical company, and Avery Posey, Jr., an instructor in the Center for Cellular Immunotherapies at the Perelman School of Medicine at the University of Pennsylvania.
Syndax Pharmaceuticals, Inc. («Syndax,» the «
Company» or «we»)(Nasdaq: SNDX), a clinical stage biopharmaceutical company developing entinostat and SNDX - 6352 in multiple cancer indications, in collaboration with The Wistar Institute and Indiana University Melvin and Bren Simon Cancer Center, today announced the publication of a preclinical report demonstrating that entinostat, Syndax's oral, Class - I histone deacetylase inhibitor, enhances the antitumor effect of PD - 1 (programmed death receptor - 1) blockade through the inhibition of myeloid derived suppressor cells (
Company» or «we»)(Nasdaq: SNDX), a clinical stage
biopharmaceutical company developing entinostat and SNDX - 6352 in multiple cancer indications, in collaboration with The Wistar Institute and Indiana University Melvin and Bren Simon Cancer Center, today announced the publication of a preclinical report demonstrating that entinostat, Syndax's oral, Class - I histone deacetylase inhibitor, enhances the antitumor effect of PD - 1 (programmed death receptor - 1) blockade through the inhibition of myeloid derived suppressor cells (
company developing entinostat and SNDX - 6352 in multiple cancer indications, in collaboration
with The Wistar Institute and Indiana University Melvin and Bren Simon Cancer Center, today announced the publication of a preclinical report demonstrating that entinostat, Syndax's oral, Class - I histone deacetylase inhibitor, enhances the antitumor effect of PD - 1 (programmed death receptor - 1) blockade through the inhibition of myeloid derived suppressor cells (MDSCs).
So Waseem Qasim at University College London created UCART19 cells
with help from Paris - based
biopharmaceutical company Cellectis instead.
The team of researchers, working
with biopharmaceutical company Autolus Ltd, have discovered a method of targeting the cancer without destroying healthy T - cells, essential to the immune system.
NEW YORK AND SAN DIEGO (Sept. 3, 2014)-- The nonprofits Ludwig Cancer Research (Ludwig) and the Cancer Research Institute (CRI) announced today an agreement
with VentiRx Pharmaceuticals Inc., a clinical stage
biopharmaceutical company, to conduct a clinical trial
with motolimod (VTX - 2337) combined
with other immunotherapy agents available to Ludwig and CRI through other industry partnerships.
SOUTH PLAINFIELD, NJ — December 6, 2007 — PTC Therapeutics, Inc. (PTC), a
biopharmaceutical company focused on the discovery, development, and commercialization of small - molecule drugs targeting post-transcriptional control mechanisms, today announced an expanded research collaboration
with the Spinal Muscular Atrophy (SMA) Foundation.
Partnering
with global
biopharmaceutical companies to make their therapies available to patients
PTC has developed proprietary technologies that it applies in its drug discovery activities and that have served as the basis for collaborations
with leading
biopharmaceutical companies such as AstraZeneca, Celgene, Genzyme, Merck, Pfizer and Roche.
Immunotherapy and small
biopharmaceutical companies as well as pharmaceutical giants all are scrambling to be first to market
with one of these medicines.
CRISPR firm Intellia Therapeutics filed an IPO and announced its collaboration
with biopharmaceutical company Regeneron.
In its inaugural collaboration that focuses on small molecule drug discovery, IACS has signed an exclusive agreement
with TESARO, Inc., an oncology - focused
biopharmaceutical company.
The research at WCPR will focus on human proteins and development and production of
biopharmaceuticals in collaboration
with pharmaceutical
companies.
Erik is a
biopharmaceutical development and operational professional
with more than 20 years of drug development, project management and manufacturing / operational experience in pharmaceutical and biotechnology
companies in North America and Europe.
Calico, the secretive Google - backed life sciences
company, today revealed plans to build what could be a $ 1.5 billion research and development center
with biopharmaceutical company AbbVie, the recent spinoff of Abbott Laboratories.
In addition, the
company collaborates
with biopharmaceutical companies in the development of companion diagnostic tests and technologies for various cancer therapies, helping to realize the promise of precision oncology.
Apexigen is a clinical - stage
biopharmaceutical company discovering and developing a new generation of antibody therapeutics for oncology,
with an emphasis on new immuno - oncology agents that could harness the patient's immune system to combat and eradicate cancer.
Chemical Biology Consortium Sweden (CBCS), a part of SciLifeLab, today announces the launch of a new
biopharmaceutical company; Glionova Therapeutics, as a result of a collaboration
with Patrik Ernfors, Professor at Karolinska Institutet.
PTC has developed proprietary technologies that it applies in its drug discovery activities and in collaborations
with leading
biopharmaceutical companies.
This constitutes a major cause of long - term sick leave and forced early retirement, placing a great financial burden on both individuals and healthcare systems.Despite extensive research programmes by
biopharmaceutical companies and academia, there remains a need for treatments that are more effective and
with fewer side - effects.
NEWMEDS brought together top scientists from academic institutions
with a wide range of expertise, and partners them
with nearly all major
biopharmaceutical companies.
An immunotherapy technology developed by Dr. Brian Till
with Dr. Oliver Press at Fred Hutchinson Cancer Research Center has been licensed by Mustang Bio Inc., a subsidiary of the
biopharmaceutical company Fortress Biotech Inc..
Mullane, director of corporate liaison and ventures, brings to Gladstone more than 20 years of executive experience working
with biopharmaceutical companies.
AVEO Pharmaceuticals, Inc. is a
biopharmaceutical company, which is discovering, developing and commercializing targeted therapies to treat patients
with cancer.
Consistent
with our responsibility as the world's leading
biopharmaceutical company, we also collaborate
with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world.
Provided advice respecting questions dealing
with human resources and the protection of privacy for various clients, including one of the largest automobile manufacturers; a Canadian leader in consumer products; a leading
company in Analog and Digital Television, High - Speed Internet and Telephone services; one of the world's largest professional services firms traded on the TSX stock exchange; one of the world's largest professional services firms, as well as a multinational corporation working in the
biopharmaceutical sector.
One legal department is looking to the future
with plans for a law firm scorecard and an objective means of evaluating outside counsel, according to a legal operations manager at a
biopharmaceutical company.